Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Pfizer CEO Albert Bourla criticized the ...
Some results have been hidden because they may be inaccessible to you